Immuto Scientific Inc. plans to use its $2.3 million in seed funding for equipment and staffing needed to take its analytical research services to market with pharmaceutical companies, according to a recent announcement. It says its technology will make drug discovery and development more efficient.
Read more at Wisconsin Inno.